Aligos Therapeutics, Inc.
ALGS • NASDAQ • Stock Fundamentals
Aligos Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lawrence Blatt, with a market cap of $32.7M.
Market Cap$32.7M
Employees67.0
CEOLawrence Blatt
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Aligos Therapeutics, Inc. FAQ
Common questions about Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. (ALGS) has a market capitalization of $32.7M and trades on NASDAQ.
Aligos Therapeutics, Inc. has approximately 67 employees.